Answers are grounded in this paper and cite their sources.
Shorter survival may be associated with high CTC counts at baseline, presence of specific CTC morphologic subtypes, PD-L1⁺ CTCs, and low %CD4/8 T cells in patients with metastatic genitourinary cancer. A future study is warranted to validate the prognostic utility of CTC heterogeneity and detection of specific CTC morphologies.
No takes yet. Share an insight, caveat, or question.
Chalfin et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: